Efficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of Migraine

NCT04384367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2068

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Rizatriptan 10 mg + Naproxen 550mg
DRUG: Maxalt 10Mg Tablet
DRUG: Flanax 550mg
DRUG: Placebo oral tablet

Sponsor

Eurofarma Laboratorios S.A.